Chongqing Zhifei Biological Products Co Ltd (300122):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Chongqing Zhifei Biological Products Co Ltd (300122) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8187
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Chongqing Zhifei Biological Products Co Ltd (Zhifei) is a vaccine manufacturer. The company offers HibACon, MeningACon, menwayc, mycobacterium vaccae, haemophilus influenzae type b conjugate vaccine and hepatitis A (live) vaccine, freeze-dried. It research, develops, produces and markets vaccines. Zhifei’s products find application in the prevention of invasive meningococcal disease, including meningitis and pneumonia; epidemic cerebrospinal meningitis, Hepatitis A and influenza. The company’s reserch and development, manufacture and marketing units are located in Beijing economic-technological development area. The company markets its products in different parts of China. Zhifei is headquartered in Chongqing, China.

Chongqing Zhifei Biological Products Co Ltd (300122) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Chongqing Zhifei Biological Products Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Chongqing Zhifei Biological Products Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Chongqing Zhifei Biological Products Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Chongqing Zhifei Biological Products Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Chongqing Zhifei Biological Products Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Chongqing Zhifei Biological Products Co Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Chongqing Zhifei Biological Products Enters into Research Agreement with Institut Pasteur of Shanghai Chinese Academy of Sciences 10
Chongqing Zhifei Biological Enters into Agreement with BD China 11
Equity Offering 12
Chongqing Zhifei Biological Plans to Raise up to USD343 Million in Private Placement of Shares 12
Chongqing Zhifei Biological Products Co Ltd – Key Competitors 13
Chongqing Zhifei Biological Products Co Ltd – Key Employees 14
Chongqing Zhifei Biological Products Co Ltd – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Chongqing Zhifei Biological Products Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Chongqing Zhifei Biological Products Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Chongqing Zhifei Biological Products Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Chongqing Zhifei Biological Products Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Chongqing Zhifei Biological Products Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Chongqing Zhifei Biological Products Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Chongqing Zhifei Biological Products Enters into Research Agreement with Institut Pasteur of Shanghai Chinese Academy of Sciences 10
Chongqing Zhifei Biological Enters into Agreement with BD China 11
Chongqing Zhifei Biological Plans to Raise up to USD343 Million in Private Placement of Shares 12
Chongqing Zhifei Biological Products Co Ltd, Key Competitors 13
Chongqing Zhifei Biological Products Co Ltd, Key Employees 14
Chongqing Zhifei Biological Products Co Ltd, Subsidiaries 15

List of Figures
Chongqing Zhifei Biological Products Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Chongqing Zhifei Biological Products Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Chongqing Zhifei Biological Products Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Chongqing Zhifei Biological Products Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Chongqing Zhifei Biological Products Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Chongqing Zhifei Biological Products Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Chongqing Zhifei Biological Products Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Chongqing Zhifei Biological Products Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Chongqing Zhifei Biological Products Co Ltd (300122):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Air T Inc:企業の戦略・SWOT・財務分析
    Air T Inc - Strategy, SWOT and Corporate Finance Report Summary Air T Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Medherant Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Medherant Ltd (Medherant) is a transdermal drug delivery patch company. The company develops and commercializes novel technologies for delivery of drugs through the skin using expertise in bioadhesives and polymer chemistry to treat pain, Alzheimer's disease, and for smoking cessation, hormo …
  • Emisphere Technologies Inc (EMIS)-製薬・医療分野:企業M&A・提携分析
    Summary Emisphere Technologies Inc (Emisphere) is a specialty pharmaceutical and drug delivery company. The company in partnership with global pharmaceutical companies develops novel oral formulations of existing injectable bio-pharmaceutical products, besides new chemical entities, using its Eligen …
  • Aerocon Engineering Company:企業の戦略・SWOT・財務情報
    Aerocon Engineering Company - Strategy, SWOT and Corporate Finance Report Summary Aerocon Engineering Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • IDT Corp (IDT):企業の財務・戦略的SWOT分析
    Summary IDT Corp (IDT) is a telecommunication service provider that offers mobile application development and telecommunication services. The company provides prepaid communication and payment services and international voice termination through its retail and wholesale division. It offers services …
  • TransMontaigne Product Services LLC:戦略・SWOT・企業財務分析
    TransMontaigne Product Services LLC - Strategy, SWOT and Corporate Finance Report Summary TransMontaigne Product Services LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Repros Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Repros Therapeutics Inc (Repros), formerly Zonagen Inc, a subsidiary of Allergan PLC, is a biopharmaceutical company that develops and markets drugs to treat hormonal and reproductive system disorders. The company’s pipeline product includes enclomiphene and proellex. Its enclomiphene is an …
  • Financial and Strategic SWOT Analysis Review
    Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportuni …
  • Axon Enterprise, Inc.:戦略・SWOT・企業財務分析
    Axon Enterprise, Inc. - Strategy, SWOT and Corporate Finance Report Summary Axon Enterprise, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • State Atomic Energy Corporation Rosatom:企業の戦略的SWOT分析
    State Atomic Energy Corporation Rosatom - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • Southwestern Electric Power Co:企業の発電所・SWOT分析2018
    Southwestern Electric Power Co - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on ke …
  • Direct Energie SA (DIREN):企業の財務・戦略的SWOT分析
    Summary Direct Energie SA (Direct Energie), formerly Poweo Direct Energie SA, a subsidiary of Total SA, is a power company that generates and distributes electricity and natural gas. The company's services include construction of combined cycle gas, electrical repair services, technical services, an …
  • Global Telecom Holding SAE:企業の戦略的SWOT分析
    Global Telecom Holding SAE - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Saracen Mineral Holdings Ltd:企業の戦略・SWOT・財務情報
    Saracen Mineral Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Saracen Mineral Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Jamnica dd:企業の戦略・SWOT・財務分析
    Jamnica dd - Strategy, SWOT and Corporate Finance Report Summary Jamnica dd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Subex Ltd (SUBEX):企業の財務・戦略的SWOT分析
    Subex Ltd (SUBEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Engepack Embalagens SA:企業の戦略・SWOT・財務情報
    Engepack Embalagens SA - Strategy, SWOT and Corporate Finance Report Summary Engepack Embalagens SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Eiger BioPharmaceuticals Inc (EIGR):製薬・医療:M&Aディール及び事業提携情報
    Summary Eiger BioPharmaceuticals Inc (Eiger), formerly Celladon Corp is a clinical-stage biopharmaceutical company that focuses on the development and commercializationof novel drugs for the treatment of orphan diseases. The company provides pipeline products such as Lonafarnib and Lambda, which are …
  • Immunicum AB (IMMU)-製薬・医療分野:企業M&A・提携分析
    Summary Immunicum AB (Immunicum) is a biopharmaceutical company that develops immuno-oncology therapies for the treatment of solid tumors. The company’s products include COMBIG, CD70, SUBCUVAX and adenovirusvector. Its SUBCUVAX is in preclinical trials in combination with the adenovirus vector for t …
  • The Israel Electric Corporation Ltd-エネルギー分野:企業M&A・提携分析
    Summary The Israel Electric Corporation Ltd (IECL), formerly Palestine Electric Corporation Ltd. is an integrated electric utility that carries out the generation, transmission, distribution, sale and supply of electricity. The State of Israel owns around 99.85% of the company. It generates power ma …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆